AOTI (LSE:AOTI) ROCE %: 16.94% (As of Dec. 2025)


LSE:AOTI AOTI Inc LSE:AOTI
21 GF Score
Price £0.63
! 8 Warning Signs
View Full Analysis

What is AOTI ROCE %?

AOTI LSE:AOTI +1.63% 21 ROCE % is 16.94% as of Dec. 2025. GuruFocus rates LSE:AOTI with a GF Score™ of 21/100. The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. AOTI's annualized ROCE % for the quarter that ended in Dec. 2025 was 16.94%.

AOTI  (LSE:AOTI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

AOTI ROCE % Related Terms

AOTI ROCE % Historical Data

* Premium members only.

The historical data trend for AOTI's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AOTI ROCE % Chart

AOTI Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
138.57 -2.06 -48.56 5.05 14.99

AOTI Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial -111.50 -26.61 23.85 10.80 16.94
LSE:AOTI
21GF Score
AOTI Inc LSE:AOTI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AOTI ROCE % Calculation

AOTI's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=4.02/( ( (31.276 - 9.112) + (41.548 - 10.064) )/ 2 )
=4.02/( (22.164+31.484)/ 2 )
=4.02/26.824
=14.99 %

AOTI's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=5.194/( ( (40.078 - 10.252) + (41.548 - 10.064) )/ 2 )
=5.194/( ( 29.826 + 31.484 )/ 2 )
=5.194/30.655
=16.94 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.94% mean?
AOTI (LSE:AOTI) has a ROCE % of 16.94% as of Dec. 2025.
Is AOTI's ROCE % too high?
AOTI's current ROCE % is 16.94%. The Medical Devices & Instruments industry median ROCE % is 2.20. AOTI's value of 16.94% is 670% above this industry median. Overall, AOTI has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does AOTI's ROCE % compare to ABT and SYK?
AOTI's ROCE % of 16.94% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. AOTI's value of 16.94% is 670% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AOTI's current ROCE % of 16.94% is 670% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AOTI's current ROCE % is 16.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AOTI stock overvalued right now?
AOTI (LSE:AOTI) has a current ROCE % of 16.94%. The current ROCE % is 16.94% and 670% above the Medical Devices & Instruments industry median of 2.20. AOTI's overall GF Score™ is 21/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For AOTI (LSE:AOTI), the current ROCE % is 16.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AOTI Business Description

Address 3512 Seagate Way, Suite 100, Oceanside, CA, USA, 92056
AOTI Inc is the design, manufacture and provision of topical oxygen therapy products and services for healthcare providers and patients with chronic wounds. These products and services enable patients to heal faster and more durably and healthcare providers to reduce the overall cost of care. The specific purposes of the Company are to patent, manufacture, rent, and sell medical devices to help resolve severe acute and chronic wounds for customers globally. The Company operates in one reportable segment, which comprises the development and sale of Creative medical devices for therapeutic care. The company's solutions includes Multi-Modality Oxygen Therapy, Extremity Chamber, Multi-Patch, Negative Pressure Wound Therapy.
21GF Score

Get the complete analysis for LSE:AOTI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.63
Price